Cargando…

Overcoming Obstacles in the Development of Antigen-Specific Immunotherapies for Type 1 Diabetes

Antigen-specific immunotherapy (ASI) holds great promise for type 1 diabetes (T1D). Preclinical success for this approach has been demonstrated in vivo, however, clinical translation is still pending. Reasons explaining the slow progress to approve ASI are complex and span all stages of research and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Ranjeny, Carballido, José M., Wesley, Johnna D., Ahmed, Simi T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375663/ https://www.ncbi.nlm.nih.gov/pubmed/34421931 http://dx.doi.org/10.3389/fimmu.2021.730414

Ejemplares similares

Potential for Antigen-Specific Tolerizing Immunotherapy in Systematic Lupus Erythematosus
por: Robinson, Sean, et al.
Publicado: (2021)

Antigen-specific immunotherapy to restore antigen-specific tolerance in Type 1 diabetes and Graves’ disease
por: Zala, Aakansha, et al.
Publicado: (2022)

Overcoming Obstacles
por: Braile, Domingo M.
Publicado: (2015)

Obstacles and Coping Strategies of CAR-T Cell Immunotherapy in Solid Tumors
por: Miao, Lele, et al.
Publicado: (2021)

Optimization of a Method to Detect Autoantigen-Specific T-Cell Responses in Type 1 Diabetes
por: Musthaffa, Yassmin, et al.
Publicado: (2020)

Non-antigenic and antigenic interventions in type 1 diabetes
por: Rydén, Anna KE, et al.
Publicado: (2013)

Chimeric Antigen Receptor Cell Therapy: Overcoming Obstacles to Battle Cancer
por: Petty, Amy J., et al.
Publicado: (2020)

Lactate from the tumor microenvironment - A key obstacle in NK cell-based immunotherapies
por: Jedlička, Marek, et al.
Publicado: (2022)

Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases
por: Richardson, Naomi, et al.
Publicado: (2020)

Overcoming Obstacles in Liquid Biopsy Developments for Prostate Cancer
por: Jang, Albert, et al.
Publicado: (2022)

Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple β-Cell Peptides in Type 1 Diabetes
por: Liu, Yuk-Fun, et al.
Publicado: (2022)

Autoantigen-Specific B-Cell Depletion Overcomes Failed Immune Tolerance in Type 1 Diabetes
por: Henry, Rachel A., et al.
Publicado: (2012)

The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy
por: Asiry, Saeed, et al.
Publicado: (2021)

Overcoming obstacles to repurposing for neurodegenerative disease
por: Shineman, Diana W, et al.
Publicado: (2014)

Overcoming Obstacles to Drug Repositioning in Japan
por: Nishimura, Yuhei, et al.
Publicado: (2017)

Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis
por: Thomas, Ranjeny
Publicado: (2013)

Immunoediting and Antigen Loss: Overcoming the Achilles Heel of Immunotherapy with Antigen Non-Specific Therapies
por: Monjazeb, Arta Monir, et al.
Publicado: (2013)

Antigen-Specific Treg Therapy in Type 1 Diabetes – Challenges and Opportunities
por: Serr, Isabelle, et al.
Publicado: (2021)

Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
por: Pham, Minh N., et al.
Publicado: (2016)

Monitoring islet specific immune responses in type 1 diabetes clinical immunotherapy trials
por: Arif, Sefina, et al.
Publicado: (2023)

Tolerogenic Immunotherapy: Targeting DC Surface Receptors to Induce Antigen-Specific Tolerance
por: Castenmiller, Charlotte, et al.
Publicado: (2021)

Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy
por: Chuntova, Pavlina, et al.
Publicado: (2019)

Determining Antigen Specificity of Human Islet Infiltrating T Cells in Type 1 Diabetes
por: Nakayama, Maki, et al.
Publicado: (2019)

Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles
por: Wong, Han Hsi, et al.
Publicado: (2010)

Sperm DNA fragmentation: overcoming standardization obstacles
por: Majzoub, Ahmad, et al.
Publicado: (2017)

Overcoming Chimeric Antigen Receptor (CAR) Modified T-Cell Therapy Limitations in Multiple Myeloma
por: García-Guerrero, Estefanía, et al.
Publicado: (2020)

Engineered RBCs Encapsulating Antigen Induce Multi-Modal Antigen-Specific Tolerance and Protect Against Type 1 Diabetes
por: Raposo, Colin J., et al.
Publicado: (2022)

Editorial: Gastrointestinal cancer immunotherapy: from drug resistance mechanisms to overcoming strategies
por: Shi, Tao, et al.
Publicado: (2023)

Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells
por: Lee, Maxwell Y, et al.
Publicado: (2021)

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
por: Peakman, Mark, et al.
Publicado: (2010)

Identifying tumor antigens and immune subtypes of renal cell carcinoma for immunotherapy development
por: Chen, Xinglin, et al.
Publicado: (2022)

Systematic Assessment of Immune Marker Variation in Type 1 Diabetes: A Prospective Longitudinal Study
por: Speake, Cate, et al.
Publicado: (2019)

Novel Tumor-Specific Antigens for Immunotherapy Identified From Multi-omics Profiling in Thymic Carcinomas
por: Fang, Wentao, et al.
Publicado: (2021)

Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-δ and –γ
por: Chandrasekaran, Sanjay, et al.
Publicado: (2021)

Development of Auto Antigen-specific Regulatory T Cells for Diabetes Immunotherapy
por: Song, Jianxun
Publicado: (2016)

Peptide Immunotherapy for Type 1 Diabetes—Clinical Advances
por: Smith, Emma L., et al.
Publicado: (2018)

An obstacle to overcome: cerebral toxoplasmosis in patients living with HIV
por: Filipescu, Irina, et al.
Publicado: (2014)

Dietary Patterns, Genes, and Health: Challenges and Obstacles to be Overcome
por: Frazier-Wood, Alexis C.
Publicado: (2014)

Recruitment, Enrollment, and Retention: Creative Techniques to Overcome Obstacles
por: Sefcik, Justine, et al.
Publicado: (2021)

Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy
por: D’Amico, Silvia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r997mhihhsijtc1ljnp3m15590